TABLE 2

Medication of the patients

Group 1 (trios with type 2 diabetes)
Group 2 (type 2 diabetes)
Group 3 (type 1 diabetes)
With diabetic nephropathyWithout diabetic nephropathyWith diabetic nephropathyWithout diabetic nephropathyWith diabetic nephropathyWithout diabetic nephropathy
n37877632136
Antidiabetic treatment
    Oral antidiabetics28.612.518.344.1*00
    Insulin57.150.060.018.6*100100
    Combination14.337.518.323.700
Other medication
    ACE inhibitor43.525.057.623.7*42.90.0*
    AT1 antagonist8.725.06.11.728.60.0*
    Combination (ACE + AT1)8.70.07.60.0*0.00.0
    β-Blockers47.875.053.327.8*33.30.0*
    Statins42.175.036.136.481.00.0*
  • Data are percent of patients on medication. Patients in the groups without diabetic nephropathy on ACE inhibitor or AT1 antagonist had undergone a 6-week washout phase before evaluation of albuminuria.

  • *

    * Significant differences between the groups with and without diabetic nephropathy.